801 related articles for article (PubMed ID: 24736487)
21. Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes.
Bolli GB; Songini M; Trovati M; Del Prato S; Ghirlanda G; Cordera R; Trevisan R; Riccardi G; Noacco C
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):571-9. PubMed ID: 18676131
[TBL] [Abstract][Full Text] [Related]
22. Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.
Fanelli CG; Pampanelli S; Porcellati F; Rossetti P; Brunetti P; Bolli GB
Ann Intern Med; 2002 Apr; 136(7):504-14. PubMed ID: 11926785
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.
Gómez AM; Marín Carrillo LF; Muñoz Velandia OM; Rondón Sepúlveda MA; Arévalo Correa CM; Mora Garzón E; Cuervo Diaz MC; Henao Carrillo DC
Diabetes Technol Ther; 2017 Feb; 19(2):109-114. PubMed ID: 28001445
[TBL] [Abstract][Full Text] [Related]
24. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
[TBL] [Abstract][Full Text] [Related]
25. Safety and Glycemic Outcomes During the MiniMed
Pihoker C; Shulman DI; Forlenza GP; Kaiserman KB; Sherr JL; Thrasher JR; Buckingham BA; Kipnes MS; Bode BW; Carlson AL; Lee SW; Latif K; Liljenquist DR; Slover RH; Dai Z; Niu F; Shin J; Jonkers RAM; Roy A; Grosman B; Vella M; Cordero TL; McVean J; Rhinehart AS; Vigersky RA;
Diabetes Technol Ther; 2023 Nov; 25(11):755-764. PubMed ID: 37782145
[No Abstract] [Full Text] [Related]
26. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
27. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia.
Oliver N; Gimenez M; Calhoun P; Cohen N; Moscardo V; Hermanns N; Freckmann G; Reddy M; Heinemann L
Diabetes Care; 2020 Jan; 43(1):53-58. PubMed ID: 31530662
[TBL] [Abstract][Full Text] [Related]
28. A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).
Ólafsdóttir AF; Polonsky W; Bolinder J; Hirsch IB; Dahlqvist S; Wedel H; Nyström T; Wijkman M; Schwarcz E; Hellman J; Heise T; Lind M
Diabetes Technol Ther; 2018 Apr; 20(4):274-284. PubMed ID: 29608107
[TBL] [Abstract][Full Text] [Related]
29. A 5-Step Approach Protocol Using CareLink Therapy Software in Type 1 Diabetes Patients.
Petrovski G; Zivkovic M
J Diabetes Sci Technol; 2017 Nov; 11(6):1277. PubMed ID: 28879783
[No Abstract] [Full Text] [Related]
30. INSULIN TIMING: A PATIENT-CENTERED APPROACH TO IMPROVE CONTROL IN TYPE 1 DIABETES.
Duran-Valdez E; Burge MR; Broderick P; Shey L; Valentine V; Schrader RM; Schade DS
Endocr Pract; 2017 Apr; 23(4):471-478. PubMed ID: 28156154
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.
Wilson DM; Calhoun PM; Maahs DM; Chase HP; Messer L; Buckingham BA; Aye T; Clinton PK; Hramiak I; Kollman C; Beck RW;
Diabetes Technol Ther; 2015 Jun; 17(6):385-91. PubMed ID: 25761202
[TBL] [Abstract][Full Text] [Related]
32. Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.
Holcombe JH; Zalani S; Arora VK; Mast CJ;
Clin Ther; 2002 Apr; 24(4):629-38. PubMed ID: 12017407
[TBL] [Abstract][Full Text] [Related]
33. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis.
Benkhadra K; Alahdab F; Tamhane SU; McCoy RG; Prokop LJ; Murad MH
Endocrine; 2017 Jan; 55(1):77-84. PubMed ID: 27477293
[TBL] [Abstract][Full Text] [Related]
34. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
[TBL] [Abstract][Full Text] [Related]
35. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
36. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
[TBL] [Abstract][Full Text] [Related]
37. Relationship of Glucose Variability With Glycated Hemoglobin and Daily Mean Glucose: A Post Hoc Analysis of Data From 5 Phase 3 Studies.
Luo J; Qu Y; Zhang Q; Chang AM; Jacober SJ
J Diabetes Sci Technol; 2018 Mar; 12(2):325-332. PubMed ID: 29056082
[TBL] [Abstract][Full Text] [Related]
38. Hypoglycemia observed during continuous glucose monitoring in patients with type 2 diabetes mellitus treated by subcutaneous insulin injection.
Ito H; Abe M; Shinozaki M; Oshikiri K; Yamashita H; Nakashima M; Takaki A; Yukawa C; Furusho M; Antoku S; Mifune M; Togane M
Diabetes Technol Ther; 2013 Jul; 15(7):586-90. PubMed ID: 23578166
[TBL] [Abstract][Full Text] [Related]
39. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.
Hirsch IB; Abelseth J; Bode BW; Fischer JS; Kaufman FR; Mastrototaro J; Parkin CG; Wolpert HA; Buckingham BA
Diabetes Technol Ther; 2008 Oct; 10(5):377-83. PubMed ID: 18715214
[TBL] [Abstract][Full Text] [Related]
40. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
